PMID: 11607041Oct 19, 2001Paper

Cardiovascular actions of berberine

Cardiovascular Drug Reviews
C W LauY Huang

Abstract

Berberine, is an alkaloid from Hydrastis canadensis L., Chinese herb Huanglian, and many other plants. It is widely used in traditional Chinese medicine as an antimicrobial in the treatment of dysentery and infectious diarrhea. This manuscript describes cardiovascular effects of berberine and its derivatives, tetrahydroberberine and 8-oxoberberine. Berberine has positive inotropic, negative chronotropic, antiarrhythmic, and vasodilator properties. Both derivatives of berberine have antiarrhythmic activity. Some cardiovascular effects of berberine and its derivatives are attributed to the blockade of K+ channels (delayed rectifier and K(ATP)) and stimulation of Na+ -Ca(2+) exchanger. Berberine has been shown to prolong the duration of ventricular action potential. Its vasodilator activity has been attributed to multiple cellular mechanisms. The cardiovascular effects of berberine suggest its possible clinical usefulness in the treatment of arrhythmias and/or heart failure.

References

Jan 1, 1979·General Pharmacology·Y T ChunU Sankawa
Oct 29, 1991·European Journal of Pharmacology·W F ChiouC F Chen
Mar 1, 1985·Journal of Cardiovascular Pharmacology·J E Shaffer
Apr 1, 1988·Clinical Cardiology·J A Marin-NetoL Gallo Júnior
Feb 1, 1972·Japanese Journal of Pharmacology·S K KulkarniN L Varandani
Sep 1, 1969·Canadian Journal of Microbiology·A H AminK M Abbasi
Jul 1, 1970·Chemical & Pharmaceutical Bulletin·H FukudaY Kudo
May 1, 1994·Journal of Cardiovascular Pharmacology·Y X WangY H Tan
Mar 1, 1993·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·K YamamotoA Suzuki
Dec 5, 1996·European Journal of Pharmacology·Y X WangX B Zhou
Aug 1, 1997·Journal of Cardiovascular Pharmacology·Y X Wang, Y M Zheng
Jan 14, 1999·British Journal of Pharmacology·W F ChiouC F Chen
Jul 8, 2000·European Journal of Pharmacology·W H KoY Huang
Mar 29, 2001·Planta medica·L D KongR X Tan

❮ Previous
Next ❯

Citations

Feb 2, 2008·The Journal of Pharmacy and Pharmacology·María Elena Sánchez-MendozaAndrés Navarrete
Jul 12, 2012·Expert Opinion on Biological Therapy·Giuseppe DerosaArrigo F G Cicero
Sep 4, 2013·BioFactors·Elisa PierpaoliMauro Provinciali
Jul 16, 2015·Journal of Cellular and Molecular Medicine·Jie WangShuang-Xi Wang
Dec 15, 2015·Frontiers in Cardiovascular Medicine·Carlo M BarbagalloMaurizio R Averna
Mar 16, 2017·The Journal of Pharmacy and Pharmacology·Xinghui WangXiao Zheng
Mar 16, 2017·Drug Metabolism Reviews·Kun WangFeng Qiu
Nov 11, 2017·The American Journal of Chinese Medicine·Yan ZanFang Huang
Aug 31, 2004·World Journal of Gastroenterology : WJG·Fang WangWei-Xing Yao
Oct 29, 2008·Evidence-based Complementary and Alternative Medicine : ECAM·Ramar Perumal Samy, Ponnampalam Gopalakrishnakone
Jan 21, 2006·Journal of Cardiovascular Pharmacology·Aldo Rodriguez-MenchacaJose A Sanchez-Chapula
Nov 1, 2007·American Journal of Physiology. Endocrinology and Metabolism·Jun YinJianping Ye
May 28, 2010·Journal of Cellular Biochemistry·Tzong-Shyuan LeeSong-Kun Shyue
May 15, 2015·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Gang HaoMan Xue
Jul 28, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yan-Xiang WangDan-Qing Song
Jul 20, 2017·Clinical and Experimental Hypertension : CHE·Mo-Li ZhuPeng Li
Jun 21, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wei ShiGuozhen Cui
May 30, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Peng XuGengli Duan
Jun 22, 2019·Clinical and Experimental Hypertension : CHE·Gaoxing ZhangXing Liu
May 18, 2010·Chinese Journal of Integrative Medicine·Min WuLong-tao Liu
Sep 15, 2010·Expert Opinion on Investigational Drugs·Parameswara Rao VuddandaSanjay Singh
Nov 1, 2013·Science China. Life Sciences·Jing YaoJianDong Jiang
Jun 26, 2020·Frontiers in Pharmacology·Junli ZhaoWenkuan Xin
Jan 18, 2003·World Journal of Gastroenterology : WJG·Fang WangWei-Xing Yao
May 27, 2004·Natural Product Reports·Kenneth W Bentley
Jan 30, 2009·American Journal of Physiology. Endocrinology and Metabolism·Woo Sik KimJae Bum Kim
Jan 16, 2010·Medicinal Research Reviews·Kakali Bhadra, Gopinatha Suresh Kumar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.